Suppression of the pathogenic effects of Strongylus edentatus larvae with thiabendazole.

The research explores the use of the medication thiabendazole to curb the harmful effects of a type of parasitic worm, Strongylus edentatus, in foals. The findings indicate that the drug appears to significantly suppress the growth and harmful effects of the larvae in infected ponies.

Purpose of the Research

The study was designed to investigate the potential of thiabendazole as a suppressor for the harmful effects caused by Strongylus edentatus larvae in pony foals. Strongylus edentatus is a species of parasitic worm that can cause serious health issues in horses and ponies.

Methods

• The researchers used four pony foals for the study.
• All the foals were exposed to Strongylus edentatus infective larvae, simulating a real-world infection scenario.
• Two of the pony foals, post three and four days of the infection, were given thiabendazole, a medicine known for broad-spectrum parasite-controlled properties.
• The administered rate of thiabendazole was 440 mg/kg of the pony’s body weight.
• The researchers tracked eosinophil (a type of white blood cell that increases in response to infection) counts, pathological changes, and the number of surviving larvae in both treated and untreated ponies.

Results

• In untreated pony foals, eosinophil counts soared to above 1700 per cubic millimeter after the second week of infection.
• In comparison, the treated ponies did not display eosinophil counts beyond 100 per cubic millimeter, similarly as in an uninfected untreated foal, indicating a significantly reduced immune response due to suppressed parasite growth.
• The treated ponies showed normal conditions in their cecum, colon, and omentum at necropsy on day 35 postinfection, with very few traces of worm activity observed on their liver surface.
• Conversely, untreated foals showed nodules on the serosal surface of their cecum and right ventral colon, along with numerous white foci and tracks on their liver surfaces, indicating significant worm activity and damage.
• At the end of the study, the researchers retrieved a total of only 53 fourth-stage larvae from the livers of the treated ponies, compared to a staggering 1194 larvae from the untreated ones, showing a substantial reduction in worm progression due to thiabendazole treatment.

Conclusion

The study demonstrates the beneficial effects of treating Strongylus edentatus infection in pony foals with thiabendazole. The drug significantly reduced the infection levels, showcased by lower eosinophil counts and less pathological damage, thus suggesting its effectiveness as a way to suppress the harmful effects of these parasites.